Danaher (NYSE:DHR)‘s stock had its “buy” rating reaffirmed by equities research analysts at Barclays in a report released on Friday. They currently have a $113.00 price objective on the conglomerate’s stock. Barclays’ price target points to a potential upside of 11.51% from the stock’s previous close.
Other equities research analysts have also issued reports about the stock. Jefferies Group restated a “buy” rating and set a $117.00 target price on shares of Danaher in a research report on Friday. Robert W. Baird restated a “buy” rating and set a $106.00 target price on shares of Danaher in a research report on Friday. Morgan Stanley boosted their target price on shares of Danaher from $110.00 to $112.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 10th. Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $109.00 target price on the stock in a research report on Wednesday, April 11th. Finally, Stifel Nicolaus restated a “buy” rating and set a $114.00 target price (up from $108.00) on shares of Danaher in a research report on Thursday. One analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $104.53.
Shares of DHR opened at $101.34 on Friday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.05 and a current ratio of 1.43. The firm has a market capitalization of $70,803.30, a price-to-earnings ratio of 25.15, a PEG ratio of 1.91 and a beta of 1.03. Danaher has a 1 year low of $78.97 and a 1 year high of $104.82.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, April 19th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.05. The company had revenue of $4.70 billion for the quarter, compared to analysts’ expectations of $4.54 billion. Danaher had a net margin of 13.56% and a return on equity of 11.59%. Danaher’s revenue was up 11.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.85 EPS. equities research analysts expect that Danaher will post 4.42 EPS for the current year.
In related news, EVP William K. Daniel sold 131,066 shares of the business’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $102.05, for a total value of $13,375,285.30. Following the sale, the executive vice president now directly owns 270,523 shares in the company, valued at approximately $27,606,872.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Angela S. Lalor sold 42,988 shares of the business’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the completion of the sale, the senior vice president now owns 82,008 shares in the company, valued at $8,388,598.32. The disclosure for this sale can be found here. Insiders sold a total of 313,260 shares of company stock worth $31,657,786 over the last quarter. Insiders own 11.90% of the company’s stock.
Several institutional investors have recently added to or reduced their stakes in DHR. BlackRock Inc. raised its stake in Danaher by 4.6% in the 4th quarter. BlackRock Inc. now owns 40,984,366 shares of the conglomerate’s stock valued at $3,804,169,000 after purchasing an additional 1,789,474 shares during the last quarter. American Century Companies Inc. raised its stake in Danaher by 81.6% in the 4th quarter. American Century Companies Inc. now owns 2,832,466 shares of the conglomerate’s stock valued at $262,909,000 after purchasing an additional 1,272,440 shares during the last quarter. Renaissance Technologies LLC raised its stake in Danaher by 1,094.1% in the 4th quarter. Renaissance Technologies LLC now owns 1,149,900 shares of the conglomerate’s stock valued at $106,734,000 after purchasing an additional 1,053,600 shares during the last quarter. Amundi Pioneer Asset Management Inc. acquired a new position in Danaher in the 4th quarter valued at about $59,642,000. Finally, Fred Alger Management Inc. raised its stake in Danaher by 26.6% in the 4th quarter. Fred Alger Management Inc. now owns 2,560,259 shares of the conglomerate’s stock valued at $237,643,000 after purchasing an additional 537,852 shares during the last quarter. Institutional investors and hedge funds own 77.65% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/04/22/barclays-reaffirms-buy-rating-for-danaher-dhr.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.